TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
44 hedge funds and large institutions have $58.4M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
42% less capital invested
Capital invested by funds: $101M → $58.4M (-$42.9M)
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
44
Holding in Top 10
2
Calls
$130K
Puts
$225K
Top Buyers
| 1 | +$473K | |
| 2 | +$372K | |
| 3 | +$260K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$213K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$113K |
Top Sellers
| 1 | -$728K | |
| 2 | -$552K | |
| 3 | -$435K | |
| 4 |
Millennium Management
New York
|
-$426K |
| 5 |
Two Sigma Investments
New York
|
-$386K |